Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
Ben-Chitrit
S
S
Dept. of Internal Medicine B, Meir General Hospital, Kfar Saba, Israel.
Korzets
Z
Z
Hershkovitz
R
R
Bernheim
J
J
Schneider
M
M
Bernheim
J
J
D000368:Aged; D017700:Embolism, Cholesterol / Q000139:chemically induced*; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D013300:Streptokinase / Q000009:adverse effects*; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
D013300:Streptokinase; D010959:Tissue Plasminogen Activator